Voyager Therapeutics Inc (NASDAQ: VYGR) is -31.52% lower on its value in year-to-date trading and has touched a low of $5.19 and a high of $11.72 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The VYGR stock was last observed hovering at around $5.67 in the last trading session, with the day’s gains setting it 0.11%.
Currently trading at $5.78, the stock is -7.76% and -11.22% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.17 million and changing 1.94% at the moment leaves the stock -25.30% off its SMA200. VYGR registered -16.23% loss for a year compared to 6-month loss of -28.99%. The firm has a 50-day simple moving average (SMA 50) of $6.5196 and a 200-day simple moving average (SMA200) of $7.74415.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -18.25% gain in the last 1 month and extending the period to 3 months gives it a -11.49%, and is 7.84% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.67% over the week and 6.04% over the month.
Voyager Therapeutics Inc (VYGR) has around 162 employees, a market worth around $315.74M and $163.78M in sales. Current P/E ratio is 8.02. Profit margin for the company is 15.80%. Distance from 52-week low is 11.37% and -50.68% from its 52-week high. The company has generated returns on investments over the last 12 months (7.02%).
The EPS is expected to shrink by -134.28% this year
180.0 institutions hold shares in Voyager Therapeutics Inc (VYGR), with institutional investors hold 78.78% of the company’s shares. The shares outstanding are 54.63M, and float is at 45.16M with Short Float at 5.41%. Institutions hold 65.40% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 5.31 million shares valued at $42.02 million. The investor’s holdings represent 9.3013 of the VYGR Shares outstanding. As of 2024-06-30, the second largest holder is ARMISTICE CAPITAL, LLC with 5.2 million shares valued at $41.13 million to account for 9.1041 of the shares outstanding. The other top investors are ECOR1 CAPITAL, LLC which holds 3.92 million shares representing 6.8588 and valued at over $30.99 million, while VANGUARD GROUP INC holds 5.3199 of the shares totaling 3.04 million with a market value of $24.04 million.
Voyager Therapeutics Inc (VYGR) Insider Activity
The most recent transaction is an insider sale by Fahey Sandell Jacquelyn, the company’s Chief Legal Officer. SEC filings show that Fahey Sandell Jacquelyn sold 5,999 shares of the company’s common stock on Oct 02 ’24 at a price of $5.82 per share for a total of $34914.0. Following the sale, the insider now owns 86001.0 shares.
Still, SEC filings show that on Apr 02 ’24, Swartz Robin (Chief Operating Officer) disposed off 1,357 shares at an average price of $9.88 for $13407.0. The insider now directly holds 117,004 shares of Voyager Therapeutics Inc (VYGR).
